Alefacept/methotrexate: Persistent CD4+ T-cell depression: 2 case reports

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1232, 2008-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab: Appearance of T-cell lymphoma: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1213, 2008-01 ,pp. : 31-31

Adis International

Access to resources Recommend Favorite

Anti-CD4 monoclonal antibody/tumour necrosis factor α inhibitors: Cytokine release syndromes, allergy, CD4+ T-cell lymphopenia and maculopapular rash: 8 case reports

Reactions Weekly, Vol. 1, Iss. 1199, 2008-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Methotrexate: Neurotoxicity: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1237, 2009-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Efalizumab/infliximab: CD8+ cutaneous T cell lymphoma (first report with efalizumab): 2 case reports

Reactions Weekly, Vol. 1, Iss. 1137, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Ciclosporin/etanercept/methotrexate: Anaplastic large T-cell lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1431, 2012-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite